<VariationArchive RecordType="classified" VariationID="30834" VariationName="NM_022089.4(ATP13A2):c.2552_2553del (p.Phe851fs)" VariationType="Deletion" Accession="VCV000030834" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-07-17" DateCreated="2017-01-20" MostRecentSubmission="2017-01-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="39791" VariationID="30834">
      <GeneList>
        <Gene Symbol="ATP13A2" FullName="ATPase cation transporting 13A2" GeneID="23400" HGNC_ID="HGNC:30213" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p36.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="16985958" stop="17011928" display_start="16985958" display_stop="17011928" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NW_025791756.1" start="1401135" stop="1427111" display_start="1401135" display_stop="1427111" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="17312452" stop="17338422" display_start="17312452" display_stop="17338422" Strand="-" />
          </Location>
          <OMIM>610513</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_022089.4(ATP13A2):c.2552_2553del (p.Phe851fs)</Name>
      <CanonicalSPDI>NC_000001.11:16989746:AAA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p36.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="16989747" stop="16989748" display_start="16989747" display_stop="16989748" variantLength="2" positionVCF="16989746" referenceAlleleVCF="CAA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="17316242" stop="17316243" display_start="17316242" display_stop="17316243" variantLength="2" positionVCF="17316241" referenceAlleleVCF="CAA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>F807fs</ProteinChange>
      <ProteinChange>F846fs</ProteinChange>
      <ProteinChange>F851fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.17316243_17316244del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.17316243_17316244del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.16989748_16989749del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.16989748_16989749del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009054.1" sequenceAccession="NG_009054" sequenceVersion="1" change="g.27181_27182del">
            <Expression>NG_009054.1:g.27181_27182del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001141973.3" sequenceAccession="NM_001141973" sequenceVersion="3" change="c.2537_2538del">
            <Expression>NM_001141973.3:c.2537_2538del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001135445.1" sequenceAccession="NP_001135445" sequenceVersion="1" change="p.Phe846fs">
            <Expression>NP_001135445.1:p.Phe846fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001141974.3" sequenceAccession="NM_001141974" sequenceVersion="3" change="c.2420_2421del">
            <Expression>NM_001141974.3:c.2420_2421del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001135446.1" sequenceAccession="NP_001135446" sequenceVersion="1" change="p.Phe807fs">
            <Expression>NP_001135446.1:p.Phe807fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_022089.4" sequenceAccession="NM_022089" sequenceVersion="4" change="c.2552_2553del" MANESelect="true">
            <Expression>NM_022089.4:c.2552_2553del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_071372.1" sequenceAccession="NP_071372" sequenceVersion="1" change="p.Phe851fs">
            <Expression>NP_071372.1:p.Phe851fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_834" sequenceAccession="LRG_834">
            <Expression>LRG_834:g.27181_27182del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_834t1" sequenceAccession="LRG_834t1">
            <Expression>LRG_834t1:c.2552_2553del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_834p1" sequenceAccession="LRG_834p1" change="p.Phe851fs">
            <Expression>LRG_834p1:p.Phe851fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA259916" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="610513.0006" DB="OMIM" />
        <XRef Type="rs" ID="587776890" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 21094623 Fig. 1C to determine the location of this deletion on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_022089.4(ATP13A2):c.2552_2553del (p.Phe851fs) AND Kufor-Rakeb syndrome" Accession="RCV000023819" Version="6">
        <ClassifiedConditionList TraitSetID="324">
          <ClassifiedCondition DB="MedGen" ID="C1847640">Kufor-Rakeb syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-02-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-01-20" MostRecentSubmission="2017-01-20">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21094623</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="324" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2530" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Park 9</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pallidopyramidal degeneration with supranuclear upgaze paresis, and dementia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Kufor-Rakeb syndrome</ElementValue>
                <XRef ID="MONDO:0011706" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PARKINSON DISEASE 9, AUTOSOMAL RECESSIVE, JUVENILE-ONSET</ElementValue>
                <XRef Type="MIM" ID="606693" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">KRS</ElementValue>
                <XRef Type="MIM" ID="606693" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">KRPPD</ElementValue>
                <XRef Type="MIM" ID="606693" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PARK9</ElementValue>
                <XRef Type="MIM" ID="606693" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9174" />
                <XRef ID="9174" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301402</ID>
                <ID Source="BookShelf">NBK1223</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23447832</ID>
                <ID Source="BookShelf">NBK121988</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS/MDS-ES, 2013">
                <ID Source="PubMed">23279440</ID>
              </Citation>
              <XRef ID="306674" DB="Orphanet" />
              <XRef ID="314632" DB="Orphanet" />
              <XRef ID="C1847640" DB="MedGen" />
              <XRef ID="MONDO:0011706" DB="MONDO" />
              <XRef Type="MIM" ID="606693" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="50366" SubmissionDate="2017-01-11" DateLastUpdated="2017-01-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="610513.0006_KUFOR-RAKEB SYNDROME" title="ATP13A2, 2-BP DEL, 2742TT_KUFOR-RAKEB SYNDROME" />
        <ClinVarAccession Accession="SCV000045110" DateUpdated="2017-01-20" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a boy, born of consanguineous Afghan parents, with Kufor-Rakeb syndrome (KRS; 606693), Crosiers et al. (2011) identified a homozygous 2-bp deletion (2742delTT) in exon 23 of the ATP13A2 gene, resulting in a premature stop codon and truncation of the protein at residue 324, causing a loss of function. There was no evidence of nonsense-mediated mRNA decay on RT-PCR analysis. The patient had mild mental retardation before onset of fine tremor of the hands and dystonic posturing of the neck at age 10 years. He also had slow vertical saccades, hypomimia, facial myoclonus, and dystonia. Cognitive function deteriorated rapidly, and he had dementia by age 11. Bradykinesia and rigidity were partially responsive to L-DOPA therapy, but he developed dyskinesias. The patient also had visual hallucinations and psychosis, and nuclear imaging showed decreased dopamine transporter binding in the right caudate nucleus and bilateral putamina. The heterozygous deletion was also found in the parents, as well as in a brother who had mild mental retardation, tremor, and decreased dopamine transporter binding in the putamina. Crosiers et al. (2011) speculated that heterozygosity for the mutation may have contributed to the brother's phenotype.</Attribute>
              <Citation>
                <ID Source="PubMed">21094623</ID>
              </Citation>
              <XRef DB="OMIM" ID="606693" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATP13A2" />
          </GeneList>
          <Name>ATP13A2, 2-BP DEL, 2742TT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 2742TT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="610513.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">KUFOR-RAKEB SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="50366" TraitType="Disease" MappingType="Name" MappingValue="KUFOR-RAKEB SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C1847640" Name="Kufor-Rakeb syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

